138 related articles for article (PubMed ID: 29228743)
1. Prognostic role of DEK in human solid tumors: a meta-analysis.
Liu G; Xiong D; Zeng J; Xu G; Xiao R; Chen B; Huang Z
Oncotarget; 2017 Nov; 8(58):98985-98992. PubMed ID: 29228743
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of HOXA13 in solid tumors: A meta-analysis.
Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G
Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis.
Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J
Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of ZEB-1 in solid tumors: a meta-analysis.
Chen B; Chen B; Zhu Z; Ye W; Zeng J; Liu G; Wang S; Gao J; Xu G; Huang Z
BMC Cancer; 2019 Jun; 19(1):635. PubMed ID: 31248382
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis.
Xiao J; Zou Y; Chen X; Gao Y; Xie M; Lu X; Li W; He B; He S; You S; Chen Q
PLoS One; 2016; 11(4):e0152674. PubMed ID: 27035914
[TBL] [Abstract][Full Text] [Related]
9. APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
Yuan CL; He F; Ye JZ; Wu HN; Zhang JY; Liu ZH; Li YQ; Luo XL; Lin Y; Liang R
Oncotarget; 2017 Aug; 8(35):59720-59728. PubMed ID: 28938675
[TBL] [Abstract][Full Text] [Related]
10. Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis.
Wang S; Zeng J; Xiao R; Xu G; Liu G; Xiong D; Ye Y; Chen B; Wang H; Luo Q; Huang Z
Cancer Manag Res; 2018; 10():1471-1478. PubMed ID: 29922091
[TBL] [Abstract][Full Text] [Related]
11. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
Xu M; Xu S
Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies.
Bian B; Li L; Yang J; Liu Y; Xie G; Zheng Y; Zeng L; Zeng J; Shen L
Cancer Cell Int; 2019; 19():259. PubMed ID: 31624472
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DcR3 in solid tumors: A meta-analysis.
Ge H; Liang C; Ren S; Yue C; Wu J
Clin Chim Acta; 2018 Jun; 481():126-131. PubMed ID: 29499202
[TBL] [Abstract][Full Text] [Related]
15. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review.
Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L
Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082
[TBL] [Abstract][Full Text] [Related]
16. CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis.
Wang S; Chen B; Zhu Z; Zhang L; Zeng J; Xu G; Liu G; Xiong D; Luo Q; Huang Z
Medicine (Baltimore); 2018 Dec; 97(52):e13832. PubMed ID: 30593179
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of p62 in solid tumor patients: a meta-analysis.
Ruan H; Xu J; Wang L; Zhao Z; Kong L; Lan B; Li X
Oncotarget; 2018 Jan; 9(3):4258-4266. PubMed ID: 29423120
[TBL] [Abstract][Full Text] [Related]
19. Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review.
Wang R; Zhang Y; Lin X; Gao Y; Zhu Y
Oncotarget; 2017 Aug; 8(34):57327-57336. PubMed ID: 28915673
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
Wu J; Hu L; Chen M; Cao W; Chen H; He T
Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
